Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Type 1 Diabetes

Endocrine, Nutritional and Metabolic Diseases

Type 1 diabetes, also called type 1 diabetes mellitus, is an autoimmune disease that occurs when the body's immune system destroys the beta cells in the pancreas that produce the hormone insulin. Insulin is used by the body to store and convert blood sugar into energy, so type 1 diabetes results in high blood sugar levels prior to treatment due to the lack of insulin. Common symptoms include frequent urination, increased thirst, increased hunger, and weight loss, and additional symptoms may include blurry vision, tiredness, and slow wound healing. While some cases take longer to develop, symptoms usually appear within weeks to a few months.

Facts
Classification
Body System
Endocrine System 1
ICD-10 Chapter
IV: Endocrine, Nutritional and Metabolic Diseases 1
Communicable or Non-communicable
Non-Communicable 2
Transmission Route
Non-Transmissible 3
Causative Agent
Causative Agent (category)
Autoimmune 3
Type 1 Diabetes
Filter Results6 entries
Connections

Treated By

Source Adoptive cell transfer (Wikipedia)
Source Automated insulin delivery system (Wikipedia)

Insulin therapy is the essential standard treatment for type 1 diabetes.

Source Islet cell transplantation (Wikipedia)
Source Pancreas Transplantation (Wikipedia)
Source Tolerogenic therapy (Wikipedia)
Sources
1. Wikipedia: ICD-10
WikipediaList of chapters, Chapter IV
Quote, List of chapters, Chapter IV
Endocrine, nutritional and metabolic diseases
View the Source
2. World Health Organization: Noncommunicable diseases (fact sheet)
World Health OrganizationMain Types section
Quote, Main Types section
The main types of NCDs are cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes.
View the Source
3. Wikipedia: Type 1 diabetes
Wikipedia
  • Article text
    Type 1 diabetes (T1D), or type 1 diabetes mellitus, is an autoimmune disease that occurs when the body's immune system destroys beta cells in the pancreas that produce the hormone insulin.
  • Lead section, transmission-route statement
    Type 1 diabetes (T1D), or type 1 diabetes mellitus, is an autoimmune disease that occurs when the body's immune system destroys beta cells in the pancreas that produce the hormone insulin.
View the Source
Islet cell transplantation (Wikipedia)
Treated By: Islet Transplantation, Lead: treats Type 1 Diabetes
Quote, Treated By: Islet Transplantation, Lead: treats Type 1 Diabetes
It is a treatment for type 1 diabetes.
View the Source
Tolerogenic therapy (Wikipedia)
Treated By: Tolerogenic Therapy, Lead: treats Type 1 Diabetes
Quote, Treated By: Tolerogenic Therapy, Lead: treats Type 1 Diabetes
Research using animal models in transplantation and autoimmune diseases has led to early-phase human trials of tolerogenic therapy for autoimmune conditions like Type 1 Diabetes.
View the Source
Pancreas Transplantation (Wikipedia)
WikipediaTreated By: Pancreas Transplantation, Article text, use for Type 1 Diabetes
Quote, Treated By: Pancreas Transplantation, Article text, use for Type 1 Diabetes
Sutherland, whole pancreas transplantation began as a part of multi-organ transplants, in the mid-to-late 1960s, at the University of Minnesota:The first attempt to cure type 1 diabetes by pancreas transplantation was done at the University of Minnesota, in Minneapolis, on December 17, 1966… [This] opened the door to a period, between the mid 70's to mid 80's where only segmental pancreatic grafts were used...
View the Source
Adoptive cell transfer (Wikipedia)
Treated By: Adoptive Cell Transfer, Autoimmune disease
Quote, Treated By: Adoptive Cell Transfer, Autoimmune disease
The transfer of regulatory T cells has been used to treat Type 1 diabetes and others.
View the Source
Automated insulin delivery system (Wikipedia)
Treated By: Automated Insulin Delivery System, Physiological
Quote, Treated By: Automated Insulin Delivery System, Physiological
In November 2018, it was announced that Defymed would partner with the Israel-based Kadimastem, a bio-pharmaceutical company developing stem-cell based regenerative therapies, to receive a two-year grant worth approximately $1.47 million for the development of a bio-artificial pancreas that would treat type 1 diabetes.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.